#BEGIN_DRUGCARD DB03059

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1420-36-6

# ChEBI_ID:
15345

# Chemical_Formula:
C25H40N7O18P3S

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3S)-3-hydroxy-2,2-dimethyl-3-{[2-({2-[(3-oxobutanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Acetoacetyl-Coenzyme A

# HET_ID:
CAA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C25H40N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-12,14,18-20,24,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/t14-,18+,19-,20+,24+/m0/s1

# InChI_Key:
InChIKey=OJFDKHTZOUZBOS-YTJNUSSGSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00332

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3059

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
851.607

# Molecular_Weight_Mono:
851.136337737

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DUB

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.37

# Predicted_LogS:
-2.4

# Predicted_Water_Solubility:
3.83e+00 g/l

# Primary_Accession_No:
DB03059

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936566

# PubChem_Substance_ID:
46506303

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00820

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](O)C(C)(C)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:52 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
BX842573

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
menB

# Drug_Target_1_Gene_Sequence:
>945 bp
TTAGAAATAGCGCGGAAACGGGCTCCAGTCGGGGGGACGCTTCTGTAGGAAGGCGTCGCG
GCCTTCGACGGCCTCGTCGGTCATGTAGGCCAGGCGGGTGGCCTCACCGGCAAACAGTTG
CTGACCCACCAGCCCGTCGTCGAGCAGGTTGAACGCGAACTTCAGCATCCGTTGCGCCTG
AGGCGATTTCGCGTTGATCTCGGCCGCCCACTGCAGCCCCACTGTCTCCAGCTCGGCGTG
TTCGGCCACCGCGTTGACCGCGCCCATCTGGTGCATCTGCTCGGCGGTGTAGGTGCGGCC
TAGGAAGAAGATCTCGCGGGCAAACTTCTGGCCGACCTGACGGGCCAGATATGCGCTGCC
GTAACCGCCATCGAAGCTGCCGACGTCGGCGTCGGTCTGCTTGAAGCGGGCGTACTCGCG
GCTGGCCAGGGTGAGATCGCAGACCACGTGCAGGCTGTGTCCCCCGCCGGCCGCCCAGCC
ATTGACCAGACAAATGACCACCTTGGGCATGAACCGGATCAGCCGCTGCACCTCCAGGAT
GTGCAACCGGCCGGCGCGGGCGACATCAACCGTGTCCGCGGTGTCTCCGCTGGCGTACTG
GTAACCGCTGCGCCCACGAATTCGTTGGTCGCCGCCGGAGCAGAACGCCCAGCCGCCGTC
CTTCGGGGACGGCCCGTTGCCGGTCAGCAGCACCACTCCGACGTCGGGCGACATTCGTGC
ATGGTCGAGCACCCGGTACAGCTCGTCGACGGTGTGCGGGCGAAATGCGTTGCGCACTTC
AGGGCGGTTGAACGCCACCCGCACCGTGGCATCGTCGACGTGGCGGTGGTAGGTGATGTC
GGTCAGATCGTCGAACCCGTCCACGAGCCGCCACGCCTTGGCATCAAAAGGGTTGTCACT
CAAGGCTGTTGAACTCCGTCCTTGTTCGCCGGCTGGAGCCACCAC

# Drug_Target_1_General_Function:
Involved in catalytic activity

# Drug_Target_1_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4574

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34689

# Drug_Target_1_Name:
PROBABLE NAPHTHOATE SYNTHASE MENB

# Drug_Target_1_Number_of_Residues:
314

# Drug_Target_1_PDB_ID:
1Q52

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00378	ECH

# Drug_Target_1_Protein_Sequence:
>PROBABLE NAPHTHOATE SYNTHASE MENB
MVAPAGEQGRSSTALSDNPFDAKAWRLVDGFDDLTDITYHRHVDDATVRVAFNRPEVRNA
FRPHTVDELYRVLDHARMSPDVGVVLLTGNGPSPKDGGWAFCSGGDQRIRGRSGYQYASG
DTADTVDVARAGRLHILEVQRLIRFMPKVVICLVNGWAAGGGHSLHVVCDLTLASREYAR
FKQTDADVGSFDGGYGSAYLARQVGQKFAREIFFLGRTYTAEQMHQMGAVNAVAEHAELE
TVGLQWAAEINAKSPQAQRMLKFAFNLLDDGLVGQQLFAGEATRLAYMTDEAVEGRDAFL
QKRPPDWSPFPRYF

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
O06414

# Drug_Target_1_SwissProt_Name:
MENB_MYCTU

# Drug_Target_1_Synonyms:
DHNA SYNTHETASE
DIHYDROXYNAPHTHOIC ACID SYNTHETASE
EC 4.1.3.36
Naphthoate synthase

# Drug_Target_1_Theoretical_pI:
6.42

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
Not Available

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Involved in acyl-CoA dehydrogenase activity

# Drug_Target_2_General_References:
7857927	Djordjevic S, Pace CP, Stankovich MT, Kim JJ: Three-dimensional structure of butyryl-CoA dehydrogenase from Megasphaera elsdenii. Biochemistry. 1995 Feb 21;34(7):2163-71.
8399220	Becker DF, Fuchs JA, Banfield DK, Funk WD, MacGillivray RT, Stankovich MT: Characterization of wild-type and an active-site mutant in Escherichia coli of short-chain acyl-CoA dehydrogenase from Megasphaera elsdenii. Biochemistry. 1993 Oct 12;32(40):10736-42.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5003

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
41409

# Drug_Target_2_Name:
Acyl-CoA dehydrogenase, short-chain specific

# Drug_Target_2_Number_of_Residues:
383

# Drug_Target_2_PDB_ID:
1BUC

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00441	Acyl-CoA_dh_1
PF02770	Acyl-CoA_dh_M
PF02771	Acyl-CoA_dh_N

# Drug_Target_2_Protein_Sequence:
>Acyl-CoA dehydrogenase, short-chain specific
MDFNLTDIQQDFLKLAHDFGEKKLAPTVTERDHKGIYDKELIDELLSLGITGAYFEEKYG
GSGDDGGDVLSYILAVEELAKYDAGVAITLSATVSLCANPIWQFGTEAQKEKFLVPLVEG
TKLGAFGLTEPNAGTDASGQQTIATKNDDGTYTLNGSKIFITNGGAADIYIVFAMTDKSK
GNHGITAFILEDGTPGFTYGKKEDKMGIHTSQTMELVFQDVKVPAENMLGEEGKGFKIAM
MTLDGGRIGVAAQALGIAEAALADAVEYSKQRVQFGKPLCKFQSISFKLADMKMQIEAAR
NLVYKAACKKQEGKPFTVDAAIAKRVASDVAMRVTTEAVQIFGGYGYSEEYPVARHMRDA
KITQIYEGTNEVQLMVTGGALLR

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Has an optimum specificity for 4-carbon length fatty acyl-CoAs

# Drug_Target_2_SwissProt_ID:
Q06319

# Drug_Target_2_SwissProt_Name:
ACDS_MEGEL

# Drug_Target_2_Synonyms:
BCAD
Butyryl-CoA dehydrogenase
EC 1.3.99.2
SCAD

# Drug_Target_2_Theoretical_pI:
4.82

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AF290086

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
mvaS

# Drug_Target_3_Gene_Sequence:
>1167 bp
TTACTCTGGTCTGTGATATTCGCGAACGTTATTTTCAATATTTGATAAGTAGAAAATATG
ACGATCTTCATGAACAGCATCTTGTTCTTCGTCAAATTCAACGTCATCAAAACGTTTGAA
GAATGTTTCATATGCATCAACAGATACTTCAGTACGGTTATTTAATAATGCTTTATGTGC
AGCTTGATCTAAATGATCTTTGTAGCCTACAACTAATGTCGCACTATAAAATTCAACAAC
TGAACCTGAGCCATAACTGAATAAACCGATTGTTTCACCAGCTTGTAAATCACGATTTTC
AAGTAATGATATTAGGCTTAAATATAATGATCCAGTATAAATATTACCGACATAACGGTT
ATAATCTACAGCATCTTCATATCCTGAACGTAAACGCTCTTGAGTTGTTTCATCAGCGTT
ATCAATGATTGACTCTAATGCCTTTTTACCCATTTTTGTAAATGGAACATGGAAGCATAG
AGATGCGAAGTCAGCTAGCGACTTACCTTGACGTTTTGCGTATTCATTCCAGCTTTGTTG
GAATGAGCGGATATAAGCATCTTTAGATAATGCACCATCAACTAATGGATATTTATGTCC
AGTTGGACGCCAGAAATCATAAACGTCTTCAGTGTAAGCAACAGCATCTTCATTTAATGC
CAAAATGCTTGGATTATGTGCAATAACCATCGCAACTGCGCCAGCACCTTGTGTTGGCTC
GCCGCCTGAATTCAATCCATAACGTGCTGTATCTGTAGCAATAACTAATACTTTTTCATT
CGGTCTAGTTGCTAAATAATCTTTAGCTAATTGAATTGCTGGTGTTGCAGCATAACAAGC
TTCTTTCATTTCAAAGCAACGTGCAAAAGGTTGAATACCTAATAAGTTGTGAATTTGAAC
AGCGGCTGCTTTAGCAGCATCAACTGCTGATTCAGTTGCCACAATTACCATACCAATTTT
CTTTTTATCTTCGTCTGTTATAATGTCCTTAGCAGCGTTAGCGCCCATTGAAACGATGTC
TTGGTTTACAGGACTAACAGCCATTTCAGTTTGACCAATTCCAATTAAAAATTTGTTTGG
GTCTACTTGGCGTGCTTCTGCTAATTTAGCCATGTCTACATAGTATTTTGGAACGTAAAA
GTTTATTTTGTCGATACCTATTGTCAT

# Drug_Target_3_General_Function:
Involved in hydroxymethylglutaryl-CoA synthase activity

# Drug_Target_3_General_References:
10894743	Wilding EI, Brown JR, Bryant AP, Chalker AF, Holmes DJ, Ingraham KA, Iordanescu S, So CY, Rosenberg M, Gwynn MN: Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci. J Bacteriol. 2000 Aug;182(15):4319-27.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
4601

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
43218

# Drug_Target_3_Name:
HMG-CoA synthase

# Drug_Target_3_Number_of_Residues:
388

# Drug_Target_3_PDB_ID:
1XPK

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01154	HMG_CoA_synt_N
PF08540	HMG_CoA_synt_C

# Drug_Target_3_Protein_Sequence:
>HMG-CoA synthase
MTIGIDKINFYVPKYYVDMAKLAEARQVDPNKFLIGIGQTEMAVSPVNQDIVSMGANAAK
DIITDEDKKKIGMVIVATESAVDAAKAAAVQIHNLLGIQPFARCFEMKEACYAATPAIQL
AKDYLATRPNEKVLVIATDTARYGLNSGGEPTQGAGAVAMVIAHNPSILALNEDAVAYTE
DVYDFWRPTGHKYPLVDGALSKDAYIRSFQQSWNEYAKRQGKSLADFASLCFHVPFTKMG
KKALESIIDNADETTQERLRSGYEDAVDYNRYVGNIYTGSLYLSLISLLENRDLQAGETI
GLFSYGSGSVVEFYSATLVVGYKDHLDQAAHKALLNNRTEVSVDAYETFFKRFDDVEFDE
EQDAVHEDRHIFYLSNIENNVREYHRPE

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
Q9FD87

# Drug_Target_3_SwissProt_Name:
Q9FD87_STAAU

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
4.72

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
BA000033

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
mvaS

# Drug_Target_4_Gene_Sequence:
>1167 bp
ATGACAATAGGTATCGATAAAATAAACTTTTACGTTCCAAAGTACTATGTAGACATGGCT
AAATTAGCAGAAGCACGCCAAGTAGATCCAAACAAATTTTTAATTGGTATTGGTCAAACT
GAAATGGCTGTTAGTCCTGTAAACCAAGACATCGTTTCAATGGGCGCTAATGCTGCTAAG
GACATTATAACAGACGAAGACAAAAAGAAAATTGGTATGGTAATTGTGGCAACTGAATCA
GCAGTTGATGCTGCTAAAGCAGCCGCTGTTCAAATTCACAACTTATTAGGTATTCAACCT
TTTGCACGTTGCTTTGAAATGAAAGAAGCTTGTTATGCTGCAACACCAGCAATTCAATTA
GCTAAAGATTATTTAGCAACTAGACCGAATGAAAAAGTATTAGTTATTGCTACAGATACA
GCACGTTATGGATTGAATTCAGGCGGCGAGCCAACACAAGGTGCTGGCGCAGTTGCGATG
GTTATTGCACATAATCCAAGCATTTTGGCATTAAATGAAGATGCTGTTGCTTACACTGAA
GACGTTTATGATTTCTGGCGTCCAACTGGACATAAATATCCATTAGTTGATGGTGCATTA
TCTAAAGATGCTTATATCCGCTCATTCCAACAAAGCTGGAATGAATACGCAAAACGTCAA
GGTAAGTCGCTAGCTGACTTCGCATCTCTATGCTTCCATGTTCCATTTACAAAAATGGGT
AAAAAGGCATTAGAGTCAATCATTGATAACGCTGATGAAACAACTCAAGAGCGTTTACGT
TCAGGATATGAAGATGCTGTAGATTATAACCGTTATGTCGGTAATATTTATACTGGATCA
TTATATTTAAGCCTAATATCATTACTTGAAAATCGTGATTTACAAGCTGGTGAAACAATC
GGTTTATTCAGTTATGGCTCAGGTTCAGTTGGTGAATTTTATAGTGCGACATTAGTTGAA
GGCTACAAAGATCATTTAGATCAAGCTGCACATAAAGCATTATTAAATAACCGTACTGAA
GTATCTGTTGATGCATATGAAACATTCTTCAAACGTTTTGATGACGTTGAATTTGACGAA
GAACAAGATGCTGTTCATGAAGATCGTCATATTTTCTACTTATCAAATATTGAAAATAAC
GTTCGCGAATATCACAGACCAGAGTAA

# Drug_Target_4_General_Function:
Involved in hydroxymethylglutaryl-CoA synthase activity

# Drug_Target_4_General_References:
12044378	Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-27.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
4589

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
43206

# Drug_Target_4_Name:
3-hydroxy-3-methylglutaryl CoA synthase

# Drug_Target_4_Number_of_Residues:
388

# Drug_Target_4_PDB_ID:
1XPK

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01154	HMG_CoA_synt_N
PF08540	HMG_CoA_synt_C

# Drug_Target_4_Protein_Sequence:
>3-hydroxy-3-methylglutaryl CoA synthase
MTIGIDKINFYVPKYYVDMAKLAEARQVDPNKFLIGIGQTEMAVSPVNQDIVSMGANAAK
DIITDEDKKKIGMVIVATESAVDAAKAAAVQIHNLLGIQPFARCFEMKEACYAATPAIQL
AKDYLATRPNEKVLVIATDTARYGLNSGGEPTQGAGAVAMVIAHNPSILALNEDAVAYTE
DVYDFWRPTGHKYPLVDGALSKDAYIRSFQQSWNEYAKRQGKSLADFASLCFHVPFTKMG
KKALESIIDNADETTQERLRSGYEDAVDYNRYVGNIYTGSLYLSLISLLENRDLQAGETI
GLFSYGSGSVGEFYSATLVEGYKDHLDQAAHKALLNNRTEVSVDAYETFFKRFDDVEFDE
EQDAVHEDRHIFYLSNIENNVREYHRPE

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
Q79ZY6

# Drug_Target_4_SwissProt_Name:
Q79ZY6_STAAW

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
4.67

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
HADH

# Drug_Target_5_GenBank_ID_Gene:
X96752

# Drug_Target_5_GenBank_ID_Protein:
1483511

# Drug_Target_5_GeneCard_ID:
HADH

# Drug_Target_5_Gene_Name:
HADH

# Drug_Target_5_Gene_Sequence:
>945 bp
ATGGCCTTCGTCACCAGGCAGTTCATGCGTTCCGTGTCCTCCTCGTCCACCGCCTCGGCC
TCGGCCAAGAAGATAATCGTCAAGCACGTGACGGTCATCGGCGGCGGGCTGATGGGCGCC
GGCATTGCCCAGGTTGCTGCAGCAACTGGTCACACAGTAGTGTTGGTAGACCAGACAGAG
GACATCCTGGCAAAATCCAAAAAGGGAATTGAGGAAAGCCTTAGGAAAGTGGCAAAGAAG
AAGTTTGCAGAAAACCCTAAGGCCGGCGATGAATTTGTGGAGAAGACCCTGAGCACCATA
GCGACCAGCACGGATGCAGCCTCCGTTGTCCACAGCACAGACTTGGTGGTGGAAGCCATC
GTGGAGAATCTGAAGGTGAAAAACGAGCTCTTCAAAAGGCTGGACAAGTTTGCTGCTGAA
CATACAATCTTTGCCAGCAACACTTCCTCCTTGCATATTACAAGCATAGCTAATGCCACC
ACCAGACAAGACCGATTCGCTGGCCTCCATTTCTTCAACCCAGTGCCTGTCATGAAACTT
GTGGAGGTCATTAAAACACCAATGACCAGCCAGAAGACATTTGAATCTTTGGTAGACTTT
AGCAAAGCCCTAGGAAAGCATCCTGTTTCTTGCAAGGACACTCCTGGGTTTATTGTGAAC
CGCCTCCTGGTTCCATACCTCATGGAAGCAATCAGGCTGTATGAACGAGGTGACGCATCC
AAAGAAGACATTGACACTGCTATGAAATTAGGAGCCGGTTACCCCATGGGCCCATTTGAG
CTTCTAGATTATGTCGGACTGGATACTACGAAGTTCATCGTGGATGGGTGGCATGAAATG
GATGCAGAGAACCCATTACATCAGCCCAGCCCATCCTTAAATAAGCTGGTAGCAGAGAAC
AAGTTCGGCAAGAAGACTGGAGAAGGATTTTACAAATACAAGTGA

# Drug_Target_5_General_Function:
Lipid transport and metabolism

# Drug_Target_5_General_References:
10231530	Barycki JJ, O'Brien LK, Bratt JM, Zhang R, Sanishvili R, Strauss AW, Banaszak LJ: Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic mechanism. Biochemistry. 1999 May 4;38(18):5786-98.
10840044	Barycki JJ, O'Brien LK, Strauss AW, Banaszak LJ: Sequestration of the active site by interdomain shifting. Crystallographic and spectroscopic evidence for distinct conformations of L-3-hydroxyacyl-CoA dehydrogenase. J Biol Chem. 2000 Sep 1;275(35):27186-96.
8687463	Vredendaal PJ, van den Berg IE, Malingre HE, Stroobants AK, Olde Weghuis DE, Berger R: Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. Biochem Biophys Res Commun. 1996 Jun 25;223(3):718-23.

# Drug_Target_5_HGNC_ID:
HGNC:4799

# Drug_Target_5_HPRD_ID:
08372

# Drug_Target_5_ID:
419

# Drug_Target_5_Locus:
4q22-q26

# Drug_Target_5_Molecular_Weight:
34278

# Drug_Target_5_Name:
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial

# Drug_Target_5_Number_of_Residues:
314

# Drug_Target_5_PDB_ID:
1F0Y

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00725	3HCDH
PF02737	3HCDH_N

# Drug_Target_5_Protein_Sequence:
>Short chain 3-hydroxyacyl-CoA dehydrogenase, mitochondrial precursor
MAFVTRQFMRSVSSSSTASASAKKIIVKHVTVIGGGLMGAGIAQVAAATGHTVVLVDQTE
DILAKSKKGIEESLRKVAKKKFAENPKAGDEFVEKTLSTIATSTDAASVVHSTDLVVEAI
VENLKVKNELFKRLDKFAAEHTIFASNTSSLQITSIANATTRQDRFAGLHFFNPVPVMKL
VEVIKTPMTSQKTFESLVDFSKALGKHPVSCKDTPGFIVNRLLVPYLMEAIRLYERGDAS
KEDIDTAMKLGAGYPMGPFELLDYVGLDTTKFIVDGWHEMDAENPLHQPSPSLNKLVAEN
KFGKKTGEGFYKYK

# Drug_Target_5_Reaction:
(S)-3-hydroxyacyl-CoA + NAD+ = 3-oxoacyl-CoA + NADH + H+

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Plays an essential role in the mitochondrial beta- oxidation of short chain fatty acids. Exerts it highest activity toward 3-hydroxybutyryl-CoA

# Drug_Target_5_SwissProt_ID:
Q16836

# Drug_Target_5_SwissProt_Name:
HCDH_HUMAN

# Drug_Target_5_Synonyms:
EC 1.1.1.35
HCDH
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial precursor
Medium and short chain L-3-hydroxyacyl-coenzyme A dehydrogenase
Short chain 3-hydroxyacyl-CoA dehydrogenase

# Drug_Target_5_Theoretical_pI:
9.41

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
J02631

# Drug_Target_6_GenBank_ID_Protein:
155618

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
phbA

# Drug_Target_6_Gene_Sequence:
>1176 bp
ATGAGCACCCCGTCCATCGTCATCGCCAGCGCCCGCACCGCGGTCGGTTCCTTCAACGGC
GCTTTCGCCAACACGCCCGCCCATGAACTCGGGGCGACCGTGATTTCGGCGGTTCTCGAG
CGCGCGGGCGTTGCGGCGGGCGAGGTGAACGAGGTGATTCTCGGCCAGGTGCTGCCGGCC
GGCGAAGGCCAGAACCCGGCCCGCCAGGCCGCCATGAAGGCCGGCGTGCCGCAGGAGGCG
ACCGCCTGGGGCATGAACCAGCTTTGCGGCTCGGGCCTGCGCGCCGTCGCGCTCGGCATG
CAGCAGATCGCCACGGGCGATGCGAGCATCATCGTCGCCGGCGGCATGGAATCCATGTCC
ATGGCCCCGCATTGCGCGCATCTGGCCGGCGTGAAGATGGGCGATTTCAAGATGATCGAC
ACGATGATCAAGGACGGCCTGACCGACGCCTTCTACGGCTACCACATGGGCACGACCGCC
GAGAATGTCGCCAAGCAGTGGCAGCTTTCCCGCGACGAGCAGGACGCCTTCGCCGTCGCC
TCGCAGAACAAGGCCGAGGCCGCCCAGAAGGACGGCCGCTTCAAGGACGAGATCGTTCCC
TTCATCGTCAAGGGCCGCAAGGGCGACATCACGGTCGATGCCGACGAATATATCCGCCAC
GGCGCGACGCTCGATTCCATGGCGAAGCTCCGCCCGGCCTTCGACAAGGAAGGCACGGTG
ACGGCCGGCAACGCCTCCGGCCTCAATGACGGCGCGGCCGCGGCCCTCCTGATGAGCGAA
GCGGAAGCCTCGCGCCGCGGCATCCAGCCGCTCGGCCGCATCGTTTCCTGGGCGACGGTC
GGCGTCGATCCCAAGGTCATGGGCACCGGCCCGATCCCGGCCTCCCGCAAGGCGCTCGAG
CGCGCCGGCTGGAAGATCGGCGATCTCGACCTCGTGGAAGCCAACGAAGCCTTCGCGGCG
CAGGCCTGCGCGGTCAACAAGGACCTCGGCTGGGATCCGTCCATCGTCAACGTCAACGGC
GGTGCCATCGCCATCGGCCACCCGATCGGCGCGTCCGGCGCCCGCATCCTCAACACGCTC
CTCTTCGAGATGAAGCGTCGCGGCGCCCGCAAGGGTCTCGCCACGCTCTGCATCGGCGGC
GGCATGGGCGTGGCGATGTGCATCGAGAGCCTTTAG

# Drug_Target_6_General_Function:
Lipid transport and metabolism

# Drug_Target_6_General_References:
10545327	Modis Y, Wierenga RK: A biosynthetic thiolase in complex with a reaction intermediate: the crystal structure provides new insights into the catalytic mechanism. Structure. 1999 Oct 15;7(10):1279-90.
10764581	Modis Y, Wierenga RK: Crystallographic analysis of the reaction pathway of Zoogloea ramigera biosynthetic thiolase. J Mol Biol. 2000 Apr 14;297(5):1171-82.
12501183	Kursula P, Ojala J, Lambeir AM, Wierenga RK: The catalytic cycle of biosynthetic thiolase: a conformational journey of an acetyl group through four binding modes and two oxyanion holes. Biochemistry. 2002 Dec 31;41(52):15543-56.
1673680	Palmer MA, Differding E, Gamboni R, Williams SF, Peoples OP, Walsh CT, Sinskey AJ, Masamune S: Biosynthetic thiolase from Zoogloea ramigera. Evidence for a mechanism involving Cys-378 as the active site base. J Biol Chem. 1991 May 5;266(13):8369-75.
2670935	Peoples OP, Sinskey AJ: Poly-beta-hydroxybutyrate biosynthesis in Alcaligenes eutrophus H16. Characterization of the genes encoding beta-ketothiolase and acetoacetyl-CoA reductase. J Biol Chem. 1989 Sep 15;264(26):15293-7.
2878929	Peoples OP, Masamune S, Walsh CT, Sinskey AJ: Biosynthetic thiolase from Zoogloea ramigera. III. Isolation and characterization of the structural gene. J Biol Chem. 1987 Jan 5;262(1):97-102.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2596

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
40474

# Drug_Target_6_Name:
Acetyl-CoA acetyltransferase

# Drug_Target_6_Number_of_Residues:
392

# Drug_Target_6_PDB_ID:
1M1T

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00108	Thiolase_N
PF02803	Thiolase_C

# Drug_Target_6_Protein_Sequence:
>Acetyl-CoA acetyltransferase
MSTPSIVIASARTAVGSFNGAFANTPAHELGATVISAVLERAGVAAGEVNEVILGQVLPA
GEGQNPARQAAMKAGVPQEATAWGMNQLCGSGLRAVALGMQQIATGDASIIVAGGMESMS
MAPHCAHLAGGVKMGDFKMIDTMIKDGLTDAFYGYHMGTTAENVAKQWQLSRDEQDAFAV
ASQNKAEAAQKDGRFKDEIVPFIVKGRKGDITVDADEYIRHGATLDSMAKLRPAFDKEGT
VTAGNASGLNDGAAAALLMSEAEASRRGIQPLGRIVSWATVGVDPKVMGTGPIPASRKAL
ERAGWKIGDLDLVEANEAFAAQACAVNKDLGWDPSIVNVNGGAIAIGHPIGASGARILNT
LLFEMKRRGARKGLATLCIGGGMGVAMCIESL

# Drug_Target_6_Reaction:
2 acetyl-CoA = CoA + acetoacetyl-CoA

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
2 acetyl-CoA = CoA + acetoacetyl-CoA

# Drug_Target_6_SwissProt_ID:
P07097

# Drug_Target_6_SwissProt_Name:
THIL_ZOORA

# Drug_Target_6_Synonyms:
Acetoacetyl-CoA thiolase
EC 2.3.1.9

# Drug_Target_6_Theoretical_pI:
6.26

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
ACADS

# Drug_Target_7_GenBank_ID_Gene:
M26393

# Drug_Target_7_GenBank_ID_Protein:
337928

# Drug_Target_7_GeneCard_ID:
ACADS

# Drug_Target_7_Gene_Name:
ACADS

# Drug_Target_7_Gene_Sequence:
>1239 bp
ATGGCCGCCGCGCTGCTCGCCCGGGCCTCGGGCCCTGCCCGCAGAGCTCTCTGTCCTAGG
GCCTGGCGGCAGTTACACACCATCTACCAGTCTGTGGAACTGCCCGAGACACACCAGATG
TTGCTCCAGACATGCCGGGACTTTGCCGAGAAGGAGTTGTTTCCCATTGCAGCCCAGGTG
GATAAGGAACATCTCTTCCCAGCGGCTCAGGTGAAGAAGATGGGCGGGCTTGGGCTTCTG
GCCATGGACGTGCCCGAGGAGCTTGGCGGTGCTGGCCTCGATTACCTGGCCTACGCCATC
GCCATGGAGGAGATCAGCCGTGGCTGCGCCTCCACCGGAGTCATCATGAGTGTCAACAAC
TCTCTCTACCTGGGGCCCATCTTGAAGTTTGGCTCCAAGGAGCAGAAGCAGGCGTGGGTC
ACGCCTTTCACCAGTGGTGACAAAATTGGCTGCTTTGCCCTCAGCGAACCAGGGAACGGC
AGTGATGCAGGAGCTGCGTCCACCACCGCCCGGGCCGAGGGCGACTCATGGGTTCTGAAT
GGAACCAAAGCCTGGATCACCAATGCCTGGGAGGCTTCGGCTGCCGTGGTCTTTGCCAGC
ACGGACAGAGCCCTGCAAAACAAGGGCATCAGTGCCTTCCTGGTCCCCATGCCAACGCCT
GGGCTCACGTTGGGGAAGAAAGAAGACAAGCTGGGCATCCGGGGCTCATCCACGGCCAAC
CTCATCTTTGAGGACTGTCGCATCCCCAAGGACAGCATCCTGGGGGAGCCAGGGATGGGC
TTCAAGATAGCCATGCAAACCCTGGACATGGGCCGCATCGGCATCGCCTCCCAGGCCCTG
GGCATTGCCCAGACCGCCCTCGATTGTGCTGTGAACTACGCTGAGAATCGCATGGCCTTC
GGGGCGCCCCTCACCAAGCTCCAGGTCATCCAGTTCAAGTTGGCAGACATGGCCCTGGCC
CTGGAGAGTGCCCGGCTGCTGACCTGGCGCGCTGCCATGCTGAAGGATAACAAGAAGCCT
TTCATCAAGGAGGCAGCCATGGCCAAGCTGGCCGCCTCGGAGGCCGCGACCGCCATCAGC
CACCAGGCCATCCAGATCCTGGGCGGCATGGGCTACGTGACAGAGATGCCGGCAGAGCGG
CACTACCGCGACGCCCGCATCACTGAGATCTACGAGGGCACCAGCGAAATCCAGCGGCTG
GTGATCGCCGGGCATCTGCTCAGGAGCTACCGGAGCTGA

# Drug_Target_7_General_Function:
Lipid transport and metabolism

# Drug_Target_7_General_References:
11134486	Corydon MJ, Vockley J, Rinaldo P, Rhead WJ, Kjeldsen M, Winter V, Riggs C, Babovic-Vuksanovic D, Smeitink J, De Jong J, Levy H, Sewell AC, Roe C, Matern D, Dasouki M, Gregersen N: Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 2001 Jan;49(1):18-23.
1286669	Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B, Vargas R, et al.: Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis. 1992 Dec;13(12):992-1001.
1692038	Naito E, Indo Y, Tanaka K: Identification of two variant short chain acyl-coenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest. 1990 May;85(5):1575-82.
2565344	Naito E, Ozasa H, Ikeda Y, Tanaka K: Molecular cloning and nucleotide sequence of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest. 1989 May;83(5):1605-13.
9383286	Corydon MJ, Andresen BS, Bross P, Kjeldsen M, Andreasen PH, Eiberg H, Kolvraa S, Gregersen N: Structural organization of the human short-chain acyl-CoA dehydrogenase gene. Mamm Genome. 1997 Dec;8(12):922-6.
9499414	Gregersen N, Winter VS, Corydon MJ, Corydon TJ, Rinaldo P, Ribes A, Martinez G, Bennett MJ, Vianey-Saban C, Bhala A, Hale DE, Lehnert W, Kmoch S, Roig M, Riudor E, Eiberg H, Andresen BS, Bross P, Bolund LA, Kolvraa S: Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C-->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G-->A, together conferring susceptibility to ethylmalonic aciduria. Hum Mol Genet. 1998 Apr;7(4):619-27.

# Drug_Target_7_HGNC_ID:
HGNC:90

# Drug_Target_7_HPRD_ID:
06053

# Drug_Target_7_ID:
839

# Drug_Target_7_Locus:
12q22-qter

# Drug_Target_7_Molecular_Weight:
44298

# Drug_Target_7_Name:
Short-chain specific acyl-CoA dehydrogenase, mitochondrial

# Drug_Target_7_Number_of_Residues:
412

# Drug_Target_7_PDB_ID:
1JQI

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00441	Acyl-CoA_dh_1
PF02770	Acyl-CoA_dh_M
PF02771	Acyl-CoA_dh_N

# Drug_Target_7_Protein_Sequence:
>Short-chain specific acyl-CoA dehydrogenase, mitochondrial precursor
MAAALLARASGPARRALCPRAWRQLHTIYQSVELPETHQMLLQTCRDFAEKELFPIAAQV
DKEHLFPAAQVKKMGGLGLLAMDVPEELGGAGLDYLAYAIAMEEISRGCASTGVIMSVNN
SLYLGPILKFGSKEQKQAWVTPFTSGDKIGCFALSEPGNGSDAGAASTTARAEGDSWVLN
GTKAWITNAWEASAAVVFASTDRALQNKGISAFLVPMPTPGLTLGKKEDKLGIRGSSTAN
LIFEDCRIPKDSILGEPGMGFKIAMQTLDMGRIGIASQALGIAQTALDCAVNYAENRMAF
GAPLTKLQVIQFKLADMALALESARLLTWRAAMLKDNKKPFIKEAAMAKLAASEAATAIS
HQAIQILGGMGYVTEMPAERHYRDARITEIYEGTSEIQRLVIAGHLLRSYRS

# Drug_Target_7_Reaction:
butanoyl-CoA + acceptor = 2-butenoyl-CoA + reduced acceptor

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not Available

# Drug_Target_7_SwissProt_ID:
P16219

# Drug_Target_7_SwissProt_Name:
ACADS_HUMAN

# Drug_Target_7_Synonyms:
Butyryl-CoA dehydrogenase
EC 1.3.99.2
SCAD
Short-chain specific acyl-CoA dehydrogenase, mitochondrial precursor

# Drug_Target_7_Theoretical_pI:
8.12

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
Not Available

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
ECHS1

# Drug_Target_8_Gene_Sequence:
Not Available

# Drug_Target_8_General_Function:
Not Available

# Drug_Target_8_General_References:
Not Available

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
7010

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
Not Available

# Drug_Target_8_Name:
Enoyl-CoA hydratase, mitochondrial

# Drug_Target_8_Number_of_Residues:
0

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
Not Available

# Drug_Target_8_Protein_Sequence:
Not Available

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
Not Available

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
P30084

# Drug_Target_8_SwissProt_Name:
ECHM_HUMAN

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
Not Available

# Drug_Target_8_Transmembrane_Regions:
Not Available

#END_DRUGCARD DB03059
